Masimo (MASI) Other Accumulated Expenses (2021 - 2022)
Masimo (MASI) recorded quarterly Other Accumulated Expenses of $183.3 million in Q4 2022, up 160.37% quarter-over-quarter from $70.4 million in Q1 2022, and up 160.37% on a YoY basis from $70.4 million in Q4 2021.
Masimo (MASI) Other Accumulated Expenses (2021 - 2022) Analysis & Trends
Masimo's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $183.3 million for Q4 2022.
- In Q4 2022, Other Accumulated Expenses rose 160.37% year-over-year to $183.3 million; the TTM figure through Dec 2022 stood at $183.3 million (up 160.37% YoY), while the FY2022 annual figure was $183.3 million, up 160.37% from the prior year.
- Other Accumulated Expenses was $183.3 million for Q4 2022 at Masimo, up from $70.4 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $183.3 million in Q4 2022 to a low of $53.2 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 183.30 Mn |
| Jan 1, 2022 | 70.40 Mn |
| Jan 2, 2021 | 53.24 Mn |